NLRP3 and Myocardial fibrosis: Gut microbial dysbiosis may promote increased AF susceptibility or AF substrates by influencing their derivatives and metabolites to modulate oxidative stress responses, regulate metabolism, and upregulate NLRP3 inflammasome expression, leading to cardiac inflammatory responses, myocardial fibrosis, or metabolic disturbances.